# Jean‐François Timsit

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jean-francois-timsit/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,037 |
| Field | Nosocomial Infections in ICU |
| h-index | 102 |
| i10-index | 375 |
| Last Known Institution | Délégation Paris 5 |
| OpenAlex ID | https://openalex.org/A5057058749 |
| ORCID iD | 0000-0002-6063-7383 |
| Works | 702 |

## Researcher papers

Showing 12 of 15.

- [Autoantibodies against type I IFNs in patients with life-threatening COVID-19](https://scholariq.org/papers/autoantibodies-against-type-i-ifns-in-patients-with-life-threatening-covid-19/)
- [Inborn errors of type I IFN immunity in patients with life-threatening COVID-19](https://scholariq.org/papers/inborn-errors-of-type-i-ifn-immunity-in-patients-with-life-threatening-covid-19/)
- [International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia](https://scholariq.org/papers/international-ers-esicm-escmid-alat-guidelines-for-the-management-of-hospital/)
- [Clinical and virological data of the first cases of COVID-19 in Europe: a case series](https://scholariq.org/papers/clinical-and-virological-data-of-the-first-cases-of-covid-19-in-europe-a-case/)
- [Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#](https://scholariq.org/papers/antimicrobial-therapeutic-drug-monitoring-in-critically-ill-adult-patients-a/)
- [Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017](https://scholariq.org/papers/prevalence-and-outcomes-of-infection-among-patients-in-intensive-care-units-in/)
- [Hydrocortisone plus Fludrocortisone for Adults with Septic Shock](https://scholariq.org/papers/hydrocortisone-plus-fludrocortisone-for-adults-with-septic-shock/)
- [Central Vein Catheter-Related Thrombosis in Intensive Care Patients](https://scholariq.org/papers/central-vein-catheter-related-thrombosis-in-intensive-care-patients/)
- [Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial](https://scholariq.org/papers/cefiderocol-versus-high-dose-extended-infusion-meropenem-for-the-treatment-of/)
- [Bloodstream infections in critically ill patients: an expert statement](https://scholariq.org/papers/bloodstream-infections-in-critically-ill-patients-an-expert-statement/)
- [Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study](https://scholariq.org/papers/characteristics-and-determinants-of-outcome-of-hospital-acquired-bloodstream/)
- [Continuous versus Intermittent Infusion of Vancomycin in Severe Staphylococcal Infections: Prospective Multicenter Randomized Study](https://scholariq.org/papers/continuous-versus-intermittent-infusion-of-vancomycin-in-severe-staphylococcal/)

## Researcher topics

- [Nosocomial Infections in ICU](https://scholariq.org/topics/nosocomial-infections-in-icu/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Central Venous Catheters and Hemodialysis](https://scholariq.org/topics/central-venous-catheters-and-hemodialysis/)
- [Antibiotic Use and Resistance](https://scholariq.org/topics/antibiotic-use-and-resistance/)

## Researcher university

- [Délégation Paris 5](https://scholariq.org/institutions/delegation-paris-5/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.